Identification of a fluorometabolite from Streptomyces sp. MA37: (2R3S4S)-5-fluoro-2,3,4-trihydroxypentanoic acid†

dc.contributor.authorMa, L.
dc.contributor.authorBartholome, A.
dc.contributor.authorTong, M.H.
dc.contributor.authorQin, Z.
dc.contributor.authorYu, Y.
dc.contributor.authorShepherd, T.
dc.contributor.authorKyerematen, K.
dc.contributor.authorDeng, H.
dc.contributor.authorHagan, D.O.
dc.date.accessioned2015-06-25T12:51:27Z
dc.date.accessioned2017-10-14T12:12:45Z
dc.date.available2015-06-25T12:51:27Z
dc.date.available2017-10-14T12:12:45Z
dc.date.issued2015
dc.description.abstract(2R3S4S)-5-Fluoro-2,3,4-trihydroxypentanoic acid (5-FHPA) has been discovered as a new fluorometabolite in the soil bacterium Streptomyces sp. MA37. Exogenous addition of 5-fluoro-5-deoxy-D-ribose (5-FDR) into the cell free extract of MA37 demonstrated that 5-FDR was an intermediate to a range of unidentified fluorometabolites, distinct from fluoroacetate (FAc) and 4-fluorothreonine (4-FT). Bioinformatics analysis allowed identification of a gene cluster (fdr), encoding a pathway to the biosynthesis of 5-FHPA. Over-expression and in vitro assay of FdrC indicated that FdrC is a NAD+ dependent dehydrogenase responsible for oxidation of 5-FDR into 5-fluoro-5-deoxy-lactone, followed by hydrolysis to 5-FHPA. The identity of 5-FHPA in the fermentation broth was confirmed by synthesis of a reference compound and then co-correlation by 19F-NMR and GC-MS analysis. The occurrence of 5-FHPA proves the existence of a new fluorometabolite pathway.en_US
dc.identifier.urihttp://197.255.68.203/handle/123456789/6334
dc.publisherChemical Scienceen_US
dc.titleIdentification of a fluorometabolite from Streptomyces sp. MA37: (2R3S4S)-5-fluoro-2,3,4-trihydroxypentanoic acid†en_US
dc.typeArticleen_US

Files

License bundle
Now showing 1 - 2 of 2
No Thumbnail Available
Name:
license.txt
Size:
1.82 KB
Format:
Item-specific license agreed upon to submission
Description:
No Thumbnail Available
Name:
license.txt
Size:
0 B
Format:
Item-specific license agreed upon to submission
Description: